Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

 

Tiziana Life Sciences plc (LSE: TILS) (the "Company") announces that on 12 September 2018, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought ordinary shares of nominal value 3p each in the capital of the Company as follows:

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 

1.	Details  of PDMR / person closely associated
a)	Name	Gabriele Cerrone/Panetta Partners Limited
2.	Reason for the notification: On market acquisition
a)	Position / status	Executive Chairman
b)	Initial notification /amendment	Initial notification
3.	Details of the issuer
a)	Name	Tiziana Life Sciences plc
b)	LEI	213800CED47HI8PIOB36
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type  of transaction; (iii) each date; and (iv) each place where transactions have  been conducted
a)	Description of the financial instrument	Ordinary Shares of nominal value 3p each
b)	Identification code of the Financial Instrument	ISIN for Tiziana Life Sciences plc: GB00BKWNZY55
c)	Nature of the transaction	Acquisition of ordinary shares
d)	Price(s) and volume(s)	Price: £1.06; Volume: 75 Price: £1.12; Volume: 2,500 Price: £1.12; Volume: 5,000
e)	Aggregated information -     Aggregated volume -     Price	7,575 £8,479.50
f)	Date of the transaction	12 September 2018
g)	Place of the transaction	XLON

 

As a result of this transaction Mr Cerrone's interests in the ordinary shares of the Company increases from 64,180,170 (50.56%) to 64,187,745 (50.57%). Mr Cerrone's interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and507,341 ordinary shares held by Panetta Partners Limited. Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

 

Contacts:

Tiziana Life Sciences plc Gabriele Cerrone, Chairman and founder	+44 (0)20 7493 2853
Cairn Financial Advisers LLP (Nominated adviser) Liam Murray / Jo Turner	+44 (0)20 7213 0883
Stockdale Securities (Broker) Antonio Bossi / Andy Crossley	+44 (0)20 7601 6100